Organ-sharing network instead of organ sellingPhilippine StarTo be detailed are not only case histories but also physical makeup, for best donee-donor matching against transplant rejection. Doctors will be trained to excise and preserve organs and tiss…
Rigel Announces Fourth Quarter and Year End 2011 Financial ResultsMarketWatch (press release)In the fourth quarter of 2011, Rigel initiated Phase 1 clinical studies of R548 with a focus on its potential to treat transplant rejection and other immune sy…
Medical Innovation and Safety: A Delicate BalanceForbesSeven medicines provide major progress in cancer treatments and almost half were judged by the FDA to be significant therapeutic advances for ailments such as kidney transplant rejection and heart …
Sharing the burden of a solitary crimeBuffalo NewsWhile he no longer has cancer, he has been hospitalized in Syracuse since Monday with shingles, a complication of an immune system impaired by transplant-rejection medication. O'Donnell was unable t…
Alexion, Zoll Lead Medical Sector In Market RallyInvestor’s Business DailyAlexion, which focuses on cancer, transplant rejection and blood disease, was last featured on Page A1 on Feb. 10. Zoll Medical (ZOLL) also has been making multiple appearances i…
Insiders Sold These Stocks on Mar-1FyxnewsAlexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threatening disease states, including hematologic and neurologic diseases, transplant…
Glucocorticoids Linked to Suicide, Neuropsychiatric DisordersMedscapeGlucocorticoid medications have anti-inflammatory properties and are commonly used to treat asthma, rheumatoid arthritis, and other autoimmune diseases and to prevent transplant rejec…
Secondhand Smoke Shortens Transplant Survival in MiceDoctors LoungeSHS did not alter acute islet allograft rejection, nor did it directly interfere with vigorously alloreactive T-cell proliferation in vivo and in vitro. SHS did not cause a significant …
Veloxis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health …Sacramento BeeMr. Koval will present an overview of the company and discuss top-line Phase 3 results of LCP-Tacro™, Veloxis' candidate to prevent organ transplant r…
Veloxis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health …PR Newswire (press release)Mr. Koval will present an overview of the company and discuss top-line Phase 3 results of LCP-Tacro™, Veloxis' candidate to prevent organ…